Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:LDRH

LDR (LDRH) Stock Price, News & Analysis

LDR logo

About LDR Stock (NASDAQ:LDRH)

Key Stats

Today's Range
$24.97
$24.99
50-Day Range
N/A
52-Week Range
$16.33
$47.12
Volume
403 shs
Average Volume
773,189 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company's primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company's VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company's Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company's traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.

Receive LDRH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LDR and its competitors with MarketBeat's FREE daily newsletter.

LDRH Stock News Headlines

Lode Resources Ltd Ordinary Shares LDR
LDR Turizm A.S.
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet
If you missed out on Nvidia, watch this video I just made.
Rival Offer for LDR Is Unlikely, but Never Say Never
Why Is Velodyne (VLDR) Stock Up 10% Today?
See More Headlines

LDRH Stock Analysis - Frequently Asked Questions

LDR Holding Co. (NASDAQ:LDRH) released its quarterly earnings results on Tuesday, May, 10th. The medical device company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.24) by $0.02. LDR's revenue was up 8.4% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that LDR investors own include Ares Acquisition (AAC), Bristol-Myers Squibb (BMY), (KITE) (KITE), Ligand Pharmaceuticals (LGND), Neurocrine Biosciences (NBIX), Nektar Therapeutics (NKTR) and Pacira BioSciences (PCRX).

Company Calendar

Last Earnings
5/10/2016
Today
11/23/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LDRH
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NASDAQ:LDRH) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners